CompletedNCT05505617

Nitric Oxide Lung Diffusing Capacity in Systemic Sclerosis

Studying Diffuse cutaneous systemic sclerosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Holger Dressel
Principal Investigator
Holger Dressel, Prof
University of Zurich
Intervention
Single-breath nitric oxide lung diffusing capacity measurements according to type of device in random order.(other)
Enrollment
9 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

University of Zurich

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05505617 on ClinicalTrials.gov

Other trials for Diffuse cutaneous systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Diffuse cutaneous systemic sclerosis →

← Back to all trials